Literature DB >> 9797553

Distribution of macrovascular disease in scleroderma.

L Stafford1, H Englert, J Gover, J Bertouch.   

Abstract

OBJECTIVE: Macrovascular disease in scleroderma has recently been described in two comparative studies. The aim of this study was to map its anatomical distribution.
METHODS: In a retrospective cohort study of 20 scleroderma patients, the results of Doppler studies of arteries in the limbs, neck, and abdomen were compared with those from 20 cohort negative patients. The latter were matched for age, sex, and the presence/absence of hypertension, hyperlipidaemia, smoking, and diabetes status. Arteries were compared quantitatively using a body surface area adjusted measurement of intraluminal diameter, and qualitatively using descriptive characteristics of the arterial walls. The latter were binomially categorised under three non-exclusive headings--thickening, stenosis, and calcification.
RESULTS: The ulnar arteries in scleroderma patients were significantly narrower than those of the negative cohort. The arterial walls were also characterised by smooth thickening along their entire length. The characteristics of the other arteries, including those of the lower limbs, were not significantly different from those of the negative cohort.
CONCLUSION: The ulnar artery seems to be specifically targeted in patients with scleroderma. Assessment of the ulnar artery should be considered in these patients by means of a modified Allen's test or Doppler sonography especially in the presence of digital gangrene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797553      PMCID: PMC1752725          DOI: 10.1136/ard.57.8.476

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  Pathogenesis of systemic sclerosis: a vascular hypothesis.

Authors:  P M Campbell; E C LeRoy
Journal:  Semin Arthritis Rheum       Date:  1975-05       Impact factor: 5.532

2.  [Hypothenar hammer syndrome as a rare cause of Raynaud syndrome].

Authors:  T Klyscz; M Jünger; S Duda; G Rassner
Journal:  Hautarzt       Date:  1996-05       Impact factor: 0.751

3.  Hypothenar hammer syndrome: an occupational cause of Raynaud's phenomenon.

Authors:  G Spencer-Green; G J Morgan; L Brown; O FitzGerald
Journal:  J Rheumatol       Date:  1987-10       Impact factor: 4.666

4.  Hypothenar hammer syndrome: posttraumatic digital ischemia.

Authors:  J Conn; J J Bergan; J L Bell
Journal:  Surgery       Date:  1970-12       Impact factor: 3.982

5.  Carotid arteritis and cerebral infarction due to scleroderma.

Authors:  J E Lee; J M Haynes
Journal:  Neurology       Date:  1967-01       Impact factor: 9.910

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

Authors:  W A D'Angelo; J F Fries; A T Masi; L E Shulman
Journal:  Am J Med       Date:  1969-03       Impact factor: 4.965

8.  Hypothenar hammer syndrome: seventeen cases with long-term follow-up.

Authors:  M Vayssairat; C Debure; J M Cormier; P Bruneval; C Laurian; Y Juillet
Journal:  J Vasc Surg       Date:  1987-06       Impact factor: 4.268

Review 9.  Vascular disease in progressive systemic sclerosis (scleroderma).

Authors:  W L Norton; J M Nardo
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

10.  Hemiplegia and peripheral gangrene secondary to large and medium size vessels involvement in C.R.E.S.T. syndrome.

Authors:  J Merino; B Casanueva; E Piney; F Val Bernal; V Rodriguez-Valverde
Journal:  Clin Rheumatol       Date:  1982-12       Impact factor: 2.980

View more
  15 in total

1.  Atherosclerosis in Systemic Sclerosis: a Modern Controversy.

Authors:  Stefania L Magda; Raluca I Mincu; Carmen M Mihai; Mircea Cinteza; Dragos Vinereanu
Journal:  Maedica (Buchar)       Date:  2015-09

2.  [Critical limb ischemia in systemic sclerosis].

Authors:  M O Becker; G Riemekasten
Journal:  Z Rheumatol       Date:  2012-06       Impact factor: 1.372

Review 3.  Is there evidence for vasculitis in systemic sclerosis?

Authors:  Lesley Ann Saketkoo; Oliver Distler
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 4.  A critical view on cardiovascular risk in systemic sclerosis.

Authors:  Antonios Psarras; Stergios Soulaidopoulos; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2016-07-12       Impact factor: 2.631

5.  Macrovascular disease and systemic sclerosis.

Authors:  M Ho; D Veale; C Eastmond; G Nuki; J Belch
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

Review 6.  Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.

Authors:  Karen Au; Manjit K Singh; Vijay Bodukam; Sangmee Bae; Paul Maranian; Rikke Ogawa; Brennan Spiegel; Maureen McMahon; Bevra Hahn; Dinesh Khanna
Journal:  Arthritis Rheum       Date:  2011-07

Review 7.  Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.

Authors:  Hasya Zinger; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

8.  Digital ischemic loss in systemic sclerosis.

Authors:  Umaima Marvi; Lorinda Chung
Journal:  Int J Rheumatol       Date:  2010-08-24

9.  Monckeberg’s sclerosis in a patient with systemic sclerosis.

Authors:  Chang-Nam Son; Kyong-Hee Jung; Soon-Young Song; Jae-Bum Jun
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

Review 10.  Ulnar artery vasculopathy in systemic sclerosis.

Authors:  Jeong Ha Park; Yoon-Kyoung Sung; Sang-Cheol Bae; Soon-Young Song; Heong Seok Seo; Jae-Bum Jun
Journal:  Rheumatol Int       Date:  2009-04-12       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.